YOVANNA GIOVANIS: Open Payments
NPI 1558013367 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$454 in 15 payments from 6 companies in 2025. Trend: 2023 $155 · 2024 $334 · 2025 $454
Food & beverage: $355Education: $99
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 4 | $168 |
| Novartis Pharmaceuticals Corporation | 3 | $82 |
| PharmaEssentia USA Corporation | 2 | $56 |
| Daiichi Sankyo Inc. | 2 | $56 |
| ABBVIE INC. | 2 | $52 |
| Apellis Pharmaceuticals, Inc. | 2 | $40 |
Products named: DARZALEX, Fabhalta, BESREMI, CREON, TECVAYLI, Empaveli, Vanflyta, Enhertu.
Industry payments across NY — which companies pay providers there.
